BBA
Baker Bros. Advisors Portfolio holdings
AUM
$10.3B
This Quarter Return
+1.77%
1 Year Return
+63.34%
3 Year Return
+231.6%
5 Year Return
+293.68%
10 Year Return
+1,612.7%
AUM
$7.1B
AUM Growth
+$7.1B
(+0.85%)
Cap. Flow
-$139M
Cap. Flow
% of AUM
-1.96%
Top 10 Holdings %
Top 10 Hldgs %
75.68%
Holding
101
New
15
Increased
16
Reduced
17
Closed
6
Top Buys
| 1 |
BioMarin Pharmaceuticals
BMRN
|
$81.5M |
| 2 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$56.4M |
| 3 |
ANAC
ANACOR PHARMACEUTICALS INC COM
ANAC
|
$27.2M |
| 4 |
DYAX
DYAX CORPORATION
DYAX
|
$15.3M |
| 5 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$13.8M |
Top Sells
| 1 |
VPHM
VIROPHARMA INC
VPHM
|
$220M |
| 2 |
Gilead Sciences
GILD
|
$51.8M |
| 3 |
PCYC
PHARMACYCLICS INC
PCYC
|
$30.8M |
| 4 |
ARIA
Ariad Pharmaceuticals Inc
ARIA
|
$24.5M |
| 5 |
AEGR
Aegerion Pharmaceuticals, Inc.
AEGR
|
$22.7M |
Sector Composition
| 1 | Healthcare | 44.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AVNR
26
DELISTED
AVANIR PHARMACEUTICALS, INC CL A
AVNR
| $18.2M | 0.26% |
5,428,591
+1,000,000
| +23% | +$3.36M |
|
|
DYAX
27
DELISTED
DYAX CORPORATION
DYAX
| $15.3M | 0.22% |
+2,026,537
| New | +$15.3M |
|
|
ACGN
28
DELISTED
Aceragen, Inc. Common Stock
ACGN
| $14.7M | 0.21% |
3,171,765
-2,693,235
| -46% | -$12.5M |
|
|
SGYP
29
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
| $14.7M | 0.21% |
2,608,271
| – | – |
|
30
Insmed
INSM
$30.3B
| $13.5M | 0.19% |
796,378
-149,425
| -16% | -$2.54M |
|
|
STML
31
DELISTED
Stemline Therapeutics, Inc.
STML
| $13.2M | 0.19% |
675,042
-125,358
| -16% | -$2.46M |
|
|
KYTH
32
DELISTED
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
| $11.7M | 0.16% |
313,191
+48,191
| +18% | +$1.8M |
|
33
Ionis Pharmaceuticals
IONS
$9.64B
| $9.84M | 0.14% |
247,036
| – | – |
|
|
ZGNX
34
DELISTED
Zogenix, Inc.
ZGNX
| $9.46M | 0.13% |
2,751,000
+750,000
| +37% | +$2.58M |
|
35
Prothena Corp
PRTA
$452M
| $8.94M | 0.13% |
336,918
-32,732
| -9% | -$868K |
|
|
MTEM
36
DELISTED
Molecular Templates, Inc.
MTEM
| $8.65M | 0.12% |
1,852,399
| – | – |
|
37
TG Therapeutics
TGTX
$5.03B
| $8.58M | 0.12% |
2,199,656
+1,599,656
| +267% | +$6.24M |
|
|
QLTI
38
DELISTED
QLT Inc
QLTI
| $8.56M | 0.12% |
1,535,863
| – | – |
|
|
WINT
39
DELISTED
Windtree Therapeutics Inc
WINT
| $8.37M | 0.12% |
3,718,617
+2,200,000
| +145% | +$4.95M |
|
|
ARRY
40
DELISTED
Array Biopharma Inc
ARRY
| $7.52M | 0.11% |
1,500,000
| – | – |
|
|
AMBI
41
DELISTED
AMBIT BIOSCIENCES CORP COM STK (DE)
AMBI
| $7.21M | 0.1% |
747,954
-8
| -0% | -$77 |
|
42
Omeros
OMER
$284M
| $6.87M | 0.1% |
608,404
| – | – |
|
43
Novavax
NVAX
$1.2B
| $6.59M | 0.09% |
1,286,913
-430,000
| -25% | -$2.2M |
|
44
Ironwood Pharmaceuticals
IRWD
$201M
| $6.34M | 0.09% |
546,160
+85,000
| +18% | +$987K |
|
|
OSIR
45
DELISTED
Osiris Therapeutics, Inc. Common Stock
OSIR
| $6.04M | 0.09% |
375,282
| – | – |
|
|
XNPT
46
DELISTED
XENOPORT, INC.
XNPT
| $5.95M | 0.08% |
1,034,112
| – | – |
|
47
Sangamo Therapeutics
SGMO
$161M
| $5.89M | 0.08% |
424,308
+247,601
| +140% | +$3.44M |
|
|
PTLA
48
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $5.78M | 0.08% |
224,434
-75,477
| -25% | -$1.94M |
|
|
AERI
49
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $5.39M | 0.08% |
+300,000
| New | +$5.39M |
|
50
Xencor
XNCR
$594M
| $5.03M | 0.07% |
+550,000
| New | +$5.03M |
|